ARCHIVES

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

Institutions Required To Review For Bias under PHS Proposal

July 22, 1994

NCI Should Examine Alternative Therapies TA Report Says

September 28, 1990

A Conversation With Daniel Masys: Acronym “CABIG” Could Be Eliminated

January 6, 2012

Letter to the Editors: AACR Defends Policy Paper And Work Of Barker, Sigal.

June 27, 2003

Zerhouni Appoints Two Institute Directors

September 13, 2002

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

October 31, 2014